Natasja M.S. de Groot
Papers
3
Total Citations
16
H-Index
2
About
Natasja M.S. de Groot is a leading cardiovascular researcher whose work centers on advancing the treatment of persistent and long-standing persistent atrial fibrillation (AF) through innovative hybrid ablation techniques. Her major contributions lie in refining robotic-enhanced hybrid ablation (RE-HA), a minimally invasive approach that combines epicardial and endocardial ablation to overcome the limitations of standard pulmonary vein isolation. In her landmark 2024 study, she reported the first European experience with robotic-assisted epicardial hybrid ablation and left appendage closure, a paper that has already garnered 12 citations for its pioneering methodology. Dr. de Groot has also identified key biophysical predictors of effective local epicardial radiofrequency ablation and, in her most recent 2025 work, demonstrated how functional conduction gaps and atrial fibrosis predict early arrhythmia recurrence after RE-HA. Her research directly addresses the critical challenge of treatment durability in complex AF patients, offering clinicians evidence-based strategies to improve outcomes. With a focused portfolio of highly cited papers, Dr. de Groot is establishing herself as a pivotal figure in the evolution of hybrid AF management.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3